Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis

• Principais autores: Rita Reyburn, MSc (Autor), Evelyn Tuivaga, MBBS (Autor), Cattram D Nguyen, PhD (Autor), Felisita T Ratu, BPHN (Autor), Devina Nand, MSc (Autor), Joe Kado, MMed (Autor), Lisi Tikoduadua, MBBS (Autor), Kylie Jenkins, MPH (Autor), Margaret de Campo, MPH (Autor), Mike Kama, MPH (Autor), Rachel Devi, MPH (Autor), Eric Rafai, MPH (Autor), Daniel M Weinberger, PhD (Autor), E Kim Mulholland, ProfMD (Autor), Fiona M Russell, ProfPhD (Autor)
• Formato: Livro
• Publicado em: Elsevier, 2021-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Summary: Background: In October, 2012, Fiji introduced routine infant immunisation with a ten-valent pneumococcal conjugate vaccine (PCV10) using three primary doses and no booster dose (3 + 0 schedule). Data are scarce for the effect of PCV in the Asia and Pacific region. We aimed to evaluate the e...